Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer

Clin Genitourin Cancer. 2020 Apr;18(2):e167-e173. doi: 10.1016/j.clgc.2019.09.017. Epub 2019 Sep 27.

Abstract

Background: We assessed preoperative pyuria as a significant predictor of intravesical recurrence (IVR) in patients with upper urinary tract urothelial carcinoma (UTUC) after radical nephroureterectomy (RNU).

Patients and methods: We evaluated the data from 268 patients with UTUC without a history of bladder cancer who had undergone RNU from 2006 to 2016 at 4 academic institutions. The associations between the clinical variables and the presence of pyuria were evaluated by univariate analysis. IVR was assessed using the Kaplan-Meier method and Cox regression analysis.

Results: The median postoperative follow-up of patients with IVR-free survival was 29.1 months (interquartile range, 15.4-55.3 months). The rate of IVR was significantly greater in the patients with than in those without pyuria (P = .025). Multivariate analysis showed that preoperative pyuria (hazard ratio [HR], 1.70; P = .007), a ureteral tumor site (HR, 1.64; P = .012), and positive surgical margins (HR, 2.70; P = .013) were associated with a significantly increased risk of IVR. A postoperative risk stratification model using these factors showed significant differences among the 3 subgroups of patients with low, intermediate, and high risk. The 5-year IVR-free survival rates for the patients with low, intermediate, and high risk were 69.1%, 51.8%, and 18.8%, respectively (P = .004).

Conclusion: Preoperative pyuria, a ureteral tumor site, and positive surgical margins were associated with a significantly increased risk of IVR. Although external validation is required, the presence of preoperative pyuria could be a significant predictor of IVR in patients with UTUC after RNU.

Keywords: Intravesical recurrence; Preoperative pyuria; Prognostic marker; Upper urinary tract; Urothelial carcinoma.

MeSH terms

  • Aged
  • Carcinoma, Transitional Cell / epidemiology*
  • Carcinoma, Transitional Cell / secondary
  • Carcinoma, Transitional Cell / surgery
  • Female
  • Follow-Up Studies
  • Humans
  • Kaplan-Meier Estimate
  • Kidney / pathology
  • Kidney / surgery
  • Kidney Neoplasms / mortality
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery*
  • Kidney Neoplasms / urine
  • Male
  • Margins of Excision
  • Nephroureterectomy*
  • Preoperative Period
  • Proportional Hazards Models
  • Pyuria / epidemiology*
  • Regression Analysis
  • Retrospective Studies
  • Risk Assessment / methods
  • Risk Factors
  • Survival Rate
  • Ureter / pathology
  • Ureter / surgery
  • Ureteral Neoplasms / mortality
  • Ureteral Neoplasms / pathology
  • Ureteral Neoplasms / surgery*
  • Ureteral Neoplasms / urine
  • Urinary Bladder / pathology
  • Urinary Bladder Neoplasms / epidemiology*
  • Urinary Bladder Neoplasms / secondary
  • Urinary Bladder Neoplasms / surgery
  • Urinary Bladder Neoplasms / urine